Zahraa Nour Eldine Ismail

Zahraa Nour Eldine Ismail

Auto-generated profile, based on publicly available information

Zahraa Nour Eldine Ismail

The British University in Egypt (BUE)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2025 in IEEE Access
Verified
Journal Article
Open access
ZIZahraa Ismail
Zahraa Ismail
AAAhmet sait ALALI
Ahmet sait ALALI
Ahmad MuhammadAhmad Muhammad
Ahmad Muhammad
MAMahmoud Ashraf
Mahmoud Ashraf
SASameh Abdellatif
Sameh Abdellatif
This study introduces a novel figure of merit for evaluating the stability of perovskite solar cells (PSCs) by employing advanced Long Short-Term Memory (LSTM) neural networks to investigate degradation mechanisms. By harnessing the power of artificial intelligence and data analytics, we analyzed extensive datasets encompassing PSC parameters, experimental results, and environmental conditions, revealing critical insights into the degradation patterns affecting cell performance over time. Our findings indicate that the LSTM model effectively captures and predicts the complex relationships between key design parameters—efficiency, fill factor, and open-circuit voltage—and degradation-induced changes in PSCs. Specifically, we identified three degradation coefficients associated with the electron transport layer, hole transport layer, and perovskite active layer. These coefficients serve as a new figure of merit, facilitating numerical studies on degradation and stability in PSCs, mainly focusing on cesium lead halides. Furthermore, the enhanced LSTM architecture, featuring deeper layers, dropout for regularization, and batch normalization, demonstrated improved stability and training speed, leading to a test Mean Absolute Error (MAE) of 0.0354 and an R² value of 0.9991, indicating near-perfect predictive accuracy. The comparative analysis of model complexity confirmed that increasing the sophistication of the LSTM model significantly enhances predictive accuracy and generalization capabilities. Identifying crucial design parameters offers actionable insights for optimizing PSC designs, materials selection, and operational conditions, ultimately contributing to enhanced long-term stability and efficiency of PSCs. Future research should prioritize using experimental datasets to achieve more realistic predictions, thereby driving innovation and unlocking the full potential of machine learning and deep learning in optimizing PSC design and performance.

30 October 2024 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
ESEman Sawires
Eman Sawires
ZIZahraa Ismail
Zahraa Ismail
FAFathy Amer
Fathy Amer
SASameh Abdellatif
Sameh Abdellatif
This paper presents a novel approach for parameter extraction and optimization of perovskite solar cells (PSCs) using a hybrid random forest (RF) machine learning model integrated with a neural network algorithm. We validated our model’s accuracy through experiments on a fabricated Cesium Lead Chloride perovskite cell, characterizing it under one sun conditions and diffused light injection. We compared the root-mean-square error (RMSE) of our model with experimental measurements and existing literature on perovskites. Additionally, we utilized measured C – V characteristics as inputs for a polynomial regression algorithm to extract C – V coefficients. Our results indicate a significant improvement in RMSE to 0.00016 with hyperparameter optimization (HPO), representing nearly a 90% enhancement over the equilibrium optimizer (EO) benchmark. Although the computational time for the ML model with HPO was approximately double that of the EO, the ML model without HPO still outperformed the EO by about 25% with only a modest increase in time. These findings underscore the effectiveness of hybrid machine learning approaches in optimizing PSC performance.

20 August 2022 in The Egyptian Rheumatologist
Verified
Journal Article
Open access
DSDR NASHWA Kamel EL SHAARAWY
DR NASHWA Kamel EL SHAARAWY
AEAlaa E. Ebrahim
Alaa E. Ebrahim
ZIZahraa N. Ismail
Zahraa N. Ismail

22 February 2022 in Egyptian Rheumatology and Rehabilitation
Verified
Journal Article
Open access
PDF file
ZIZahraa Nour Eldine Ismail
Zahraa Nour Eldine Ismail
Background: Rheumatoid arthritis (RA) patients have a risk of fractures due to secondary osteoporosis. This study aimed to evaluate the probability of fractures in the next 10 years in Egyptian RA patients by the Fracture Risk Assessment Tool (FRAX). Results: The study was a case–control study. It included a hundred RA patients as well as 51 apparently healthy volunteers. Bone mineral density (BMD) means of lumbar vertebra, femoral neck, and total femur were significantly lower in the RA patient group. Additionally, FRAX of the major osteoporotic and hip fractures means were significantly higher in the RA group than in the control group. It was also found that age, body mass index (BMI), Health Assessment Questionnaire Disability Index (HAQ-DI), and BMD of the femoral neck were significant predictors of FRAX of major osteoporotic and hip fractures (P ≤ 0.05). The cumulative dose of steroids was a significant predictor for FRAX of major osteoporotic fractures; however, the 28 joints disease activity score calculated with erythrocyte sedimentation rate (ESR) (DAS28-ESR) was a significant predictor for FRAX of hip fractures. Conclusions: RA patients have a high fracture risk probability. Regular annual screening for BMD and FRAX of major osteoporotic and hip fractures is necessary for those patients.

27 April 2023 in Egyptian Rheumatology and Rehabilitation
Verified
Journal Article
Open access
PDF file
ZIZahraa Nour Eldine Ismail
Zahraa Nour Eldine Ismail
MHMohamed Ahmed Hefny
Mohamed Ahmed Hefny
AHAhmed Elarabi Hendi
Ahmed Elarabi Hendi
MTMarwa G. Tawfik
Marwa G. Tawfik
Background: Patients with rheumatic diseases significantly suffer during and after infection with coronavirus disease (COVID-19). Post-COVID-19 syndrome (PCS) refers to signs and symptoms occurring during or following a COVID-19 infection that continue beyond 12 weeks. The study aimed to assess PCS symptoms in rheumatic disease patients compared to a control group not suffering from a rheumatic disease or any other chronic illness.Results: The prevalence of PCS symptoms was significantly higher in rheumatic disease patients compared to the control group: fatigue (69.1% vs. 41.25%), myalgia (73.5% vs. 37.5%), attention deficits (57.4% vs. 40%), and muscle weakness (33.8% vs. 13.8%). Objectively, the study group had significantly higher scores for the Fatigue Severity Scale (FSS) (35.46 ± 13.146 vs. 25.1 ± 7.587), Short-form McGill Pain Questionnaire (SF-MPQ-2) (21.66 ± 10.3 vs. 11.6 ± 3.433), and higher grades of functional disability in the Post-COVID-19 Functional Status scale (PCFS). Rheumatic disease patients had significantly higher frequencies of anxiety and depression, as assessed by the Hospital Anxiety and Depression Scale (HADS), and cognitive impairment, as assessed by the Mini-Mental State Examination (MMSE), than the controls (P = 0.023,P = 0.003,P = 0.0001, respectively). Moreover, SLE patients had the most symptoms and the highest FSS, SF-MPQ-2, PCFS, and HADS scores, as well as the lowest MMSE scores (P = 0.0001 for all except cough (P = 0.043), weakness (P = 0.015), paresthesia (P = 0.027), and anosmia (P = 0.039)). Lower disease duration, hospitalization during acute COVID-19, steroid use, smoking, and biologics non-use were significantly associated with higher PCS symptoms. Smoking was a significant risk factor (P = 0.048), and biologics use was protective (P = 0.03). Rheumatic disease patients who received two doses of the COVID-19 vaccinations had better scores on the FSS, HADS for anxiety and depression, and MMSE than those who received a single dose (P = 0.005,P = 0.001,P = 0.009,P = 0.01).Conclusion: Rheumatic disease patients have a higher prevalence and risk of PCS, so strict follow-up, avoiding smoking, controlling disease activity, and COVID-19 vaccinations are essential for decreasing the morbidity of PCS.

16 June 2022 in Egyptian Rheumatology and Rehabilitation
Verified
Journal Article
Open access
PDF file
ZIZahraa Nour Eldine Ismail
Zahraa Nour Eldine Ismail
MHMohamed Ahmed Hefny
Mohamed Ahmed Hefny
AHAhmed Elarabi Hendi
Ahmed Elarabi Hendi
Background: Resilience is the process of adjusting successfully in the face of adversity, trauma, threats, or severe stress, such as serious health problems. It is one of the factors that affect recovery from psychiatric disorders. It was suggested that fibromyalgia patients have low resilience. This study aimed to assess the impact of resilience on disease severity and psychiatric comorbidities in patients with fibromyalgia. Results: We found that patients with fibromyalgia had a significantly lower resilience and higher prevalence of psychiatric comorbidities than the control group (P < 0.05). Also, fibromyalgia patients with high disease severity had a significantly lower resilience and a higher percentage of psychiatric problems than those with a better disease state (P = 0.0001). Also, there was a significant negative correlation of resilience with disease severity (as assessed by the FIQ score), visual analog scale (VAS) of anxiety, and VAS of depression (P = 0.0001). Conclusion: Resilience significantly impacts the severity and psychiatric comorbidities in patients with fibromyalgia. So, enhancing and improving resilience must be considered in the management protocols of fibromyalgia patients.